REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Finusolprima Farma Internasional (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Finusolprima Farma Internasional Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Finusolprima Farma Internasional is an enterprise located in Indonesia, with the main office in Bekasi. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. PT Finusolprima Farma Internasional was incorporated on 1981. The company’s latest financial report indicates a net sales revenue increase of 5.17% in 2023. Its’ total assets recorded a growth of 2.01%.

Headquarters
Kawasan Industri Rawa Pasung, RT 006 RW 001
Bekasi; West Java; Postal Code: 17133

Contact Details: Purchase the PT Finusolprima Farma Internasional report to view the information.

Website: http://www.kalbe.co.id

Basic Information
Outstanding Shares:
Purchase the PT Finusolprima Farma Internasional report to view the information.
Registered Capital:
Purchase the PT Finusolprima Farma Internasional report to view the information.
Incorporation Date:
1981
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Finusolprima Farma Internasional report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.17%
Total operating revenue
5.17%
Total assets
2.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?